Cargando…

Human Beta-Defensin 3 Is Up-Regulated in Cutaneous Leprosy Type 1 Reactions

BACKGROUND: Leprosy, a chronic granulomatous disease affecting the skin and nerves, is caused by Mycobacterium leprae (M. leprae). The type of leprosy developed depends upon the host immune response. Type 1 reactions (T1Rs), that complicate borderline and lepromatous leprosy, are due to an increase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cogen, Anna L., Walker, Stephen L., Roberts, Chrissy H., Hagge, Deanna A., Neupane, Kapil D., Khadge, Saraswoti, Lockwood, Diana N. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486878/ https://www.ncbi.nlm.nih.gov/pubmed/23133681 http://dx.doi.org/10.1371/journal.pntd.0001869

Ejemplares similares

Diagnosis and Treatment of Leprosy Reactions in Integrated Services - The Patients' Perspective in Nepal
por: Raffe, Sonia F., et al.
Publicado: (2013)

T-Cell Regulation in Lepromatous Leprosy
por: Bobosha, Kidist, et al.
Publicado: (2014)

Diagnosis and impact of neuropathic pain in leprosy patients in Nepal after completion of multidrug therapy
por: Toh, Han-Siong, et al.
Publicado: (2018)

A Phase Two Randomised Controlled Double Blind Trial of High Dose Intravenous Methylprednisolone and Oral Prednisolone versus Intravenous Normal Saline and Oral Prednisolone in Individuals with Leprosy Type 1 Reactions and/or Nerve Function Impairment
por: Walker, Stephen L., et al.
Publicado: (2011)

Safety and Efficacy Assessment of Two New Leprosy Skin Test Antigens: Randomized Double Blind Clinical Study
por: Rivoire, Becky L., et al.
Publicado: (2014)

Opening a Can of Worms: Leprosy Reactions and Complicit Soil-Transmitted Helminths
por: Hagge, Deanna A., et al.
Publicado: (2017)

Longitudinal immune profiles in type 1 leprosy reactions in Bangladesh, Brazil, Ethiopia and Nepal
por: Khadge, Saraswoti, et al.
Publicado: (2015)

Whole blood RNA signatures in leprosy patients identify reversal reactions before clinical onset: a prospective, multicenter study
por: Tió-Coma, Maria, et al.
Publicado: (2019)

Differential Dermal Expression of CCL17 and CCL18 in Tuberculoid and Lepromatous Leprosy
por: Berrington, William R., et al.
Publicado: (2014)

Comparing the Clinical and Histological Diagnosis of Leprosy and Leprosy Reactions in the INFIR Cohort of Indian Patients with Multibacillary Leprosy
por: Lockwood, Diana N. J., et al.
Publicado: (2012)

Development and Validation of a Severity Scale for Leprosy Type 1 Reactions
por: Walker, Stephen L., et al.
Publicado: (2008)

Household Costs of Leprosy Reactions (ENL) in Rural India
por: Chandler, David J., et al.
Publicado: (2015)

A leprosy clinical severity scale for erythema nodosum leprosum: An international, multicentre validation study of the ENLIST ENL Severity Scale
por: Walker, Stephen L., et al.
Publicado: (2017)

Identification of a systemic interferon-γ inducible antimicrobial gene signature in leprosy patients undergoing reversal reaction
por: Teles, Rosane M. B., et al.
Publicado: (2019)

Effectiveness of 32 versus 20 weeks of prednisolone in leprosy patients with recent nerve function impairment: A randomized controlled trial
por: Wagenaar, Inge, et al.
Publicado: (2017)

Gene Expression of Human Beta-Defensin-3 and Cathelicidin in the Skin of Leprosy Patients, Household Contacts, and Healthy Individuals from Indonesia
por: Argentina, Fifa, et al.
Publicado: (2023)

The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions
por: Negera, Edessa, et al.
Publicado: (2018)

Understanding the roles of gingival beta-defensins
por: Gursoy, Ulvi Kahraman, et al.
Publicado: (2012)

A Randomized Controlled Double Blind Trial of Ciclosporin versus Prednisolone in the Management of Leprosy Patients with New Type 1 Reaction, in Ethiopia
por: Lambert, Saba M., et al.
Publicado: (2016)

Comparison of Efficacy of Doxycycline and Isotretinoin on Cutaneous Human Beta-Defensin-1 and -2 Levels in Acne Vulgaris
por: Aksoy, Gülhan, et al.
Publicado: (2018)

Patients with skin smear positive leprosy in Bangladesh are the main risk factor for leprosy development: 21-year follow-up in the household contact study (COCOA)
por: Quilter, Emily E. V., et al.
Publicado: (2020)

Single lesion multibacillary leprosy, a treatment enigma: a case report
por: Sapkota, Bishwa R, et al.
Publicado: (2009)

Expressions of Antimicrobial Peptides LL-37, Human Beta Defensin-2 and -3 in the Lesions of Cutaneous Tuberculosis and Tuberculids
por: Zhao, Zheng, et al.
Publicado: (2016)

Directional and balancing selection in human beta-defensins
por: Hollox, Edward J, et al.
Publicado: (2008)

Androgenic regulation of beta-defensins in the mouse epididymis
por: Hu, Shuang-Gang, et al.
Publicado: (2014)

IL-10 and NOS2 Modulate Antigen-Specific Reactivity and Nerve Infiltration by T Cells in Experimental Leprosy
por: Hagge, Deanna A., et al.
Publicado: (2014)

Post-exposure prophylaxis (PEP) efficacy of rifampin, rifapentine, moxifloxacin, minocycline, and clarithromycin in a susceptible-subclinical model of leprosy
por: Lenz, Shannon M., et al.
Publicado: (2020)

Leprosy and American cutaneous leishmaniasis coinfection
por: Mercadante, Larissa Mondadori, et al.
Publicado: (2018)

Interpreting data in policy & control: The case of leprosy
por: Medley, Graham F., et al.
Publicado: (2017)

Understanding leprosy reactions and the impact on the lives of people affected: An exploration in two leprosy endemic countries
por: Putri, Annisa Ika, et al.
Publicado: (2022)

The Yin and Yang of Human Beta-Defensins in Health and Disease
por: Weinberg, Aaron, et al.
Publicado: (2012)

Human Beta Defensins and Cancer: Contradictions and Common Ground
por: Ghosh, Santosh K., et al.
Publicado: (2019)

An individual randomised efficacy trial of autologous blood products, leukocyte and platelet-rich fibrin (L-PRF), to promote ulcer healing in leprosy in Nepal: the TABLE trial protocol
por: Napit, Indra B., et al.
Publicado: (2021)

Analysis of Antibody and Cytokine Markers for Leprosy Nerve Damage and Reactions in the INFIR Cohort in India
por: Jadhav, Rupendra, et al.
Publicado: (2011)

AZALEP a randomized controlled trial of azathioprine to treat leprosy nerve damage and Type 1 reactions in India: Main findings
por: Lockwood, Diana N. J., et al.
Publicado: (2017)

Non-Trophic Cutaneous Ulcers in Lepromatous Leprosy
por: Kesav, Praveen, et al.
Publicado: (2013)

Cytokine and Protein Markers of Leprosy Reactions in Skin and Nerves: Baseline Results for the North Indian INFIR Cohort
por: Lockwood, Diana N. J., et al.
Publicado: (2011)

Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract
por: Becknell, Brian, et al.
Publicado: (2013)

Cervicovaginal levels of human beta defensins during bacterial vaginosis
por: Noda-Nicolau, Nathalia Mayumi, et al.
Publicado: (2021)

Impact of smoking on protein levels of beta-defensins in periodontal disease
por: Soldati, Kahena Rodrigues, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d6v45ad6c5668pblsbclsp6dm5